OrbiMed Advisors LLC's Form 4 filing
Damora Therapeutics, Inc. (DMRA) · filed Aug 2, 2023
- Accession no.
- 0000947871-23-000809
- Filed
- Aug 2, 2023, 5:05 PM ET
- Trade date
- Jul 31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $628.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Israel GP II, L.P.CIK 0001682090 | 10% Owner |
| OrbiMed Advisors Israel II LtdCIK 0001682093 | 10% Owner |
| OrbiMed Capital GP VII LLCCIK 0001760648 | 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 31, 2023 | Common Stock | SSaleDisposed | −26,622 | $3.00 | −$79,866 | 135,531 | Indirect | |
| Jul 31, 2023 | Common Stock | SSaleDisposed | −29,700 | $3.00 | −$89,100 | 879,867 | Indirect | |
| Jul 31, 2023 | Common Stock | SSaleDisposed | −153,078 | $3.00 | −$459,234 | 2,105,909 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.